Gil Roth, Editor05.15.08
- Small/Mid-Tier Pharma - 25.7%
- Big Pharma - 23.6%
- Virtual Pharma - 12.1%
- Generic Pharma - 12.1%
- Emerging Biopharma - 10.0%
- Specialty Pharma - 5.7%
- Big Bio - 3.6%
- Other - 7.1%
Slow & Steady?
Last year, 22% of total respondents believed that they'd spend the same or less on outsourcing in the coming year; this year, that number dropped to 16%. Last year, 30% of respondents reported they'd increase outsourcing spending by 10% or more in the coming year; that number dropped to 23% this time around.
The percentage of respondents who believe that their outsourcing expenditure will increase from 1-5% from the previous year nearly doubled, from 17% in the previous survey to 32% this time around. The portion who will increase outsourcing spending from 6-10% in the coming year was nearly steady, dropping from 32% to 29%.
PS: Thanks to all who took the time to respond to this year's Outsourcing Survey. The winner of our 80gb iPod Classic drawing is Syed Yousuf of Pfizer! Congratulations!